YOLFTbeta
Heron Neutron Medical Corp.

Heron Neutron Medical Corp.

7799 · TW · Healthcare / Medical Devices

478.00TWD+17.00 (+3.69%)

Price History

Full chart

Market Stats

Previous Close461.00
Open470.00
Day Range456.00 – 494.00
52-Week Range300.00 – 747.00
Volume1.35M
Market Cap85.93B
P/E (TTM)0.00
Forward P/E0.00
EPS-3.04
Dividend Yield0.00%
50-Day Avg406.09
200-Day Avg406.79

About

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Xiao-Lian Shen
  • Employees104
  • HeadquartersNo. 66-2, Shengyi 5th Road, Zhubei, Taiwan, 302041, Taiwan
  • Websitehttps://www.heron-neutron.com

Leadership

  • Mr. Xiao-Lian ShenGeneral Manager
  • Mr. Wenzhen WangCFO & Deputy GM
  • Mr. Yan-Da WuDeputy General Manager of the Career Development Center
  • Mr. Cheng-sung LinDeputy General Manager of the Clinical Medical Center
  • Mr. Wei-Lin ChenDeputy General Manager of the R&D Engineering Center

Financials

Income Statement

Currency: TWD2022-12-312023-12-312024-12-312025-12-31
Total Revenue0238.00K010.31M
Growth (%)---100.00%-
Cost of Revenue0109.00K3.59M36.09M
Gross Profit0129.00K-3.59M-25.78M
Gross Margin-54.20%--250.12%
Operating Expense87.80M129.64M255.41M508.54M
Operating Income-87.80M-129.51M-259.00M-534.32M
Operating Margin--54415.97%--5183.58%
EBITDA-71.95M-110.77M-239.30M-441.15M
EBITDA Margin--46540.34%--4279.71%
Net Income-86.18M-126.39M-260.08M-481.67M
Net Income Margin--53105.04%--4672.74%
R&D51.57M84.84M173.39M321.87M
R&D as % of Total Revenue-35649.16%-3122.48%
Interest Expense280.00K243.00K183.00K887.00K
Interest Expense % of Total Revenue-102.10%-8.60%

Balance Sheet

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets501.05M631.06M835.11M1.54B11.58B
Total Liabilities6.39M40.59M28.71M71.96M89.30M
Total Equity494.65M590.48M806.40M1.47B11.49B
Cash5.10M7.87M233.27M723.97M2.35B

Cash Flow

Currency: TWD2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-62.05M-54.56M-259.97M-484.40M
Capital Expenditure113.98M56.19M48.98M30.08M
Free Cash Flow-176.02M-110.76M-308.95M-514.48M
FCF to OCF283.70%202.98%118.84%106.21%

Key Statistics & Ratios

Market Cap85.93B
Enterprise Value74.85B
Trailing P/E0.00
Forward P/E0.00
Price / Sales7351.10
Price / Book7.53
EPS-3.04
Book Value70.67
Revenue (TTM)11.69M
Gross Profit (TTM)-18.00M
EBITDA-565.60M
Profit Margin0.00%
Operating Margin-28243.85%
Return on Equity-7.67%
Return on Assets-5.75%
Shares Outstanding158.25M
Shares Float51.22M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%